Form D · Pharmaceuticals

BRIDGE PHARMACEUTICALS, INC.

Gaithersburg, MD · CIK 0001363234

Offering snapshot reported Aug 7, 2009 · SEC filing

Reported sold
$2.19M
Offering amount: $4.34M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 24, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 7, 2009Initial$2,188,388No comparison5SEC filing
Apr 19, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 5, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-89730
The Total Amount Sold represents the sale and issuance of Subordinated Secured Convertible Promissory Notes in the aggregate amount of $2,146,620.32 and warrants to purchase preference shares that, if exercised, would result in proceeds of $41,768.54.

Source: Form D, filed Aug 7, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Charles "Jiggs" Davis Director
Thomas J. De Loia Executive
Patrik Jeanmonod Executive
Vincent Lagrotteria Executive
Ronald Marler Director, Executive
Thomas Oakley Director, Executive
Carlos Orantes Executive
Dennis Purcell Director
Anthony Sun Director
Helen Wong Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
610 Professional Dr.
Gaithersburg, MD, 20879